Please wait a minute...
Protein & Cell

ISSN 1674-800X

ISSN 1674-8018(Online)

CN 11-5886/Q

Postal Subscription Code 80-984

2018 Impact Factor: 7.575

Prot Cell    2011, Vol. 2 Issue (5) : 369-376    https://doi.org/10.1007/s13238-011-1051-0      PMID: 21667332
RESEARCH ARTICLE
Conserved arginine residue in the membrane-spanning domain of HIV-1 gp41 is required for efficient membrane fusion
Yufei Long1,2, Fanxia Meng1, Naoyuki Kondo1,3, Aikichi Iwamoto4, Zene Matsuda1,5()
1. China-Japan Joint Laboratory of Structural Virology and Immunology, Institute of Biophysics, Chinese Academy of Sciences, 15 Datun Road, Beijing 100101, China; 2. Graduate University of the Chinese Academy of Sciences, Beijing 100101, China; 3. Department of Pediatrics, Emory University School of Medicine, 2015 Uppergate Dr. Atlanta, GA 30322, USA; 4. Division of Infectious Diseases, Advanced Clinical Research Center, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan; 5. Research Center for Asian Infectious Diseases, Institute of Medical Science, University of Tokyo, 4-6-1 Shirokanedai, Minato-ku, Tokyo 108-8639, Japan
 Download: PDF(286 KB)   HTML
 Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract

Despite the high mutation rate of HIV-1, the amino acid sequences of the membrane-spanning domain (MSD) of HIV-1 gp41 are well conserved. Arginine residues are rarely found in single membrane-spanning domains, yet an arginine residue, R696 (the numbering is based on that of HXB2), is highly conserved in HIV-1 gp41. To examine the role of R696, it was mutated to K, A, I, L, D, E, N, and Q. Most of these substitutions did not affect the expression, processing or surface distribution of the envelope protein (Env). However, a syncytia formation assay showed that the substitution of R696 with amino acid residues other than K, a naturally observed mutation in the gp41 MSD, decreased fusion activity. Substitution with hydrophobic amino acid residues (A, I, and L) resulted in a modest decrease, while substitution with D or E, potentially negatively-charged residues, almost abolished the syncytia formation. All the fusion-defective mutants showed slower kinetics with the cell-based dual split protein (DSP) assay that scores the degree of membrane fusion based on pore formation between fusing cells. Interestingly, the D and E substitutions did show some fusion activity in the DSP assays, suggesting that proteins containing D or E substitutions retained some fusion pore-forming capability. However, nascent pores failed to develop, due probably to impaired activity in the pore enlargement process. Our data show the importance of this conserved arginine residue for efficient membrane fusion.

Keywords human immunodeficiency virus      type-1 (HIV-1)      gp41      membrane-spanning domain (MSD)      arginine      membrane fusion     
Corresponding Author(s): Matsuda Zene,Email:zmatsuda@ims.u-tokyo.ac.jp   
Issue Date: 01 May 2011
 Cite this article:   
Naoyuki Kondo,Aikichi Iwamoto,Zene Matsuda, et al. Conserved arginine residue in the membrane-spanning domain of HIV-1 gp41 is required for efficient membrane fusion[J]. Prot Cell, 2011, 2(5): 369-376.
 URL:  
https://academic.hep.com.cn/pac/EN/10.1007/s13238-011-1051-0
https://academic.hep.com.cn/pac/EN/Y2011/V2/I5/369
Fig.1  Conservation of the arginine residue in the MSD region among different clades of HIV-1 and Arg-substitution mutants used in this study.
(A) Consensus sequences of HIV-1 gp41 MSD of different clades were from the Los Alamos HIV sequence database (http://www.hiv.lanl.gov/content/index). The predicted MSD is indicated with capital letters. (B) Substitution mutations used in this study. Mutants were constructed using a QuikChange site mutation kit based on the HXB2 strain. Substitute amino acid residues are underlined. Lysine is potentially positively-charged, like arginine. Aspartic acid and glutamic acid have a negatively-charged side chain. Asparagine and glutamine share the same backbone with aspartic acid and glutamic acid, respectively, but lack their negative charge. Alanine, leucine and isoleucine were chosen to represent uncharged amino acids.
Fig.1  Conservation of the arginine residue in the MSD region among different clades of HIV-1 and Arg-substitution mutants used in this study.
(A) Consensus sequences of HIV-1 gp41 MSD of different clades were from the Los Alamos HIV sequence database (http://www.hiv.lanl.gov/content/index). The predicted MSD is indicated with capital letters. (B) Substitution mutations used in this study. Mutants were constructed using a QuikChange site mutation kit based on the HXB2 strain. Substitute amino acid residues are underlined. Lysine is potentially positively-charged, like arginine. Aspartic acid and glutamic acid have a negatively-charged side chain. Asparagine and glutamine share the same backbone with aspartic acid and glutamic acid, respectively, but lack their negative charge. Alanine, leucine and isoleucine were chosen to represent uncharged amino acids.
Fig.2  Protein profiles of the R-substitution mutants.
The envelope proteins expressed in COS-7 cells transiently transfected with the Env expression vectors for WT or mutants were detected with anti-gp120 polyclonal antibody. The gp160 and gp120 bands are indicated.
Fig.2  Protein profiles of the R-substitution mutants.
The envelope proteins expressed in COS-7 cells transiently transfected with the Env expression vectors for WT or mutants were detected with anti-gp120 polyclonal antibody. The gp160 and gp120 bands are indicated.
Fig.3  Fusion activity and fusion kinetics of R-substitution mutants in the cell-cell fusion assay.
(A) The fusion activity was measured by syncytia formation assay. 293CD4 cells were transfected with different mutants or WT, as well as Env KO as a negative control. Nuclei of cells were stained with Hoechst. Relative fusion activity was quantified by using a fusion index (fusion index= 2 + , where is the number of multinucleated cells [number of nuclei≥5 in five visual fields] and is the number of multinucleated cells [number of nuclei<5 in five visual fields]). Fusion activities for each mutant are shown after normalization to that of WT (with WT activity set normalized to 100%). Similar results were obtained from three independent experiments. Statistical significance of the difference between the RI and RL, RD and RN, RE and RQ mutants, respectively was determined using -test. (B) DSP assay was performed to monitor the kinetics of pore formation. luciferase (RL) activity was measured from 0–5 h after co-culture. Firefly luciferase (FL) activity from parallel 293FT cells was measured to normalize transfection efficiency. RL activity normalized by FL activity was shown to reflect the fusion kinetics.
Fig.3  Fusion activity and fusion kinetics of R-substitution mutants in the cell-cell fusion assay.
(A) The fusion activity was measured by syncytia formation assay. 293CD4 cells were transfected with different mutants or WT, as well as Env KO as a negative control. Nuclei of cells were stained with Hoechst. Relative fusion activity was quantified by using a fusion index (fusion index= 2 + , where is the number of multinucleated cells [number of nuclei≥5 in five visual fields] and is the number of multinucleated cells [number of nuclei<5 in five visual fields]). Fusion activities for each mutant are shown after normalization to that of WT (with WT activity set normalized to 100%). Similar results were obtained from three independent experiments. Statistical significance of the difference between the RI and RL, RD and RN, RE and RQ mutants, respectively was determined using -test. (B) DSP assay was performed to monitor the kinetics of pore formation. luciferase (RL) activity was measured from 0–5 h after co-culture. Firefly luciferase (FL) activity from parallel 293FT cells was measured to normalize transfection efficiency. RL activity normalized by FL activity was shown to reflect the fusion kinetics.
Fig.4  Level of surface expression of R-substitution mutants.
COS-7 cells were transfected with WT or mutants and subjected to immunofluorescence assays without permeabilization. Surface-expressed gp120 was detected by staining with 2G12 primary antibody and APC-conjugated secondary antibody. Internal EGFP signal was used as an indicator of transfected cells. Representative confocal microscopic images are shown.
Fig.4  Level of surface expression of R-substitution mutants.
COS-7 cells were transfected with WT or mutants and subjected to immunofluorescence assays without permeabilization. Surface-expressed gp120 was detected by staining with 2G12 primary antibody and APC-conjugated secondary antibody. Internal EGFP signal was used as an indicator of transfected cells. Representative confocal microscopic images are shown.
1 Bonifacino, J.S., Cosson, P., Shah, N., and Klausner, R.D. (1991). Role of potentially charged transmembrane residues in targeting proteins for retention and degradation within the endoplasmic reticulum. EMBO J 10, 2783-2793 .
pmid:1915263
2 Ciczora, Y., Callens, N., Montpellier, C., Bartosch, B., Cosset, F.L., Op de Beeck, A., and Dubuisson, J. (2005). Contribution of the charged residues of hepatitis C virus glycoprotein E2 transmembrane domain to the functions of the E1E2 heterodimer. J Gen Virol 86, 2793-2798 .
pmid:16186234
3 Colman, P.M., and Lawrence, M.C. (2003). The structural biology of type I viral membrane fusion. Nat Rev Mol Cell Biol 4, 309-319 .
pmid:12671653
4 Davis, G.L., and Hunter, E. (1987). A charged amino acid substitution within the transmembrane anchor of the Rous sarcoma virus envelope glycoprotein affects surface expression but not intracellular transport. J Cell Biol 105, 1191-1203 .
pmid:2821009
5 Dubay, J.W., Dubay, S.R., Shin, H.J., and Hunter, E. (1995). Analysis of the cleavage site of the human immunodeficiency virus type 1 glycoprotein: requirement of precursor cleavage for glycoprotein incorporation. J Virol 69, 4675-4682 .
pmid:7609032
6 Freed, E.O., and Martin, M.A. (1996). Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions. J Virol 70, 341-351 .
pmid:8523546
7 Gangupomu, V.K., and Abrams, C.F. (2010). All-atom models of the membrane-spanning domain of HIV-1 gp41 from metadynamics. Biophys J 99, 3438-3444 .
pmid:21081093
8 Gu, M., Rappaport, J., and Leppla, S.H. (1995). Furin is important but not essential for the proteolytic maturation of gp160 of HIV-1. FEBS Lett 365, 95-97 .
pmid:7774724
9 Haffar, O.K., Dowbenko, D.J., and Berman, P.W. (1988). Topogenic analysis of the human immunodeficiency virus type 1 envelope glycoprotein, gp160, in microsomal membranes. J Cell Biol 107, 1677-1687 .
pmid:3053734
10 Helseth, E., Olshevsky, U., Gabuzda, D., Ardman, B., Haseltine, W., and Sodroski, J. (1990). Changes in the transmembrane region of the human immunodeficiency virus type 1 gp41 envelope glycoprotein affect membrane fusion. J Virol 64, 6314-6318 .
pmid:2243396
11 Hessa, T., Kim, H., Bihlmaier, K., Lundin, C., Boekel, J., Andersson, H., Nilsson, I., White, S.H., and von Heijne, G. (2005). Recognition of transmembrane helices by the endoplasmic reticulum translocon. Nature 433, 377-381 .
pmid:15674282
12 Kabat, D., Kozak, S.L., Wehrly, K., and Chesebro, B. (1994). Differences in CD4 dependence for infectivity of laboratory-adapted and primary patient isolates of human immunodeficiency virus type 1. J Virol 68, 2570-2577 .
pmid:8139036
13 Kim, J.H., Hartley, T.L., Curran, A.R., and Engelman, D.M. (2009). Molecular dynamics studies of the transmembrane domain of gp41 from HIV-1. Biochim Biophys Acta 1788, 1804-1812 .
pmid:19540828
14 Kitchen, S.G., and Zack, J.A. (1997). CXCR4 expression during lymphopoiesis: implications for human immunodeficiency virus type 1 infection of the thymus. J Virol 71, 6928-6934 .
pmid:9261420
15 Kondo, N., Miyauchi, K., and Matsuda, Z. (2011). Monitoring viral-mediated membrane fusion using fluorescent reporter methods. Curr Protoc Cell Biol Chapter 26, Unit 26.9 .
16 Kondo, N., Miyauchi, K., Meng, F., Iwamoto, A., and Matsuda, Z. (2010). Conformational changes of the HIV-1 envelope protein during membrane fusion are inhibited by the replacement of its membrane-spanning domain. J Biol Chem 285, 14681-14688 .
pmid:20197275
17 Li, L., Vorobyov, I., MacKerell, A.D. Jr, and Allen, T.W. (2008). Is arginine charged in a membrane? Biophys J 94, L11-L13 .
pmid:17981901
18 Liu, S., Kondo, N., Long, Y., Xiao, D., Iwamoto, A., and Matsuda, Z. (2010). Membrane topology analysis of HIV-1 envelope glycoprotein gp41. Retrovirology 7, 100.
pmid:21118523
19 Melikyan, G.B. (2008). Common principles and intermediates of viral protein-mediated fusion: the HIV-1 paradigm. Retrovirology 5, 111.
pmid:19077194
20 Miyauchi, K., Curran, A.R., Long, Y., Kondo, N., Iwamoto, A., Engelman, D.M., and Matsuda, Z. (2010). The membrane-spanning domain of gp41 plays a critical role in intracellular trafficking of the HIV envelope protein. Retrovirology 7, 95.
pmid:21073746
21 Miyauchi, K., Komano, J., Yokomaku, Y., Sugiura, W., Yamamoto, N., and Matsuda, Z. (2005). Role of the specific amino acid sequence of the membrane-spanning domain of human immunodeficiency virus type 1 in membrane fusion. J Virol 79, 4720-4729 .
pmid:15795258
22 Morton, H.C., van den Herik-Oudijk, I.E., Vossebeld, P., Snijders, A., Verhoeven, A.J., Capel, P.J., and van de Winkel, J.G. (1995). Functional association between the human myeloid immunoglobulin A Fc receptor (CD89) and FcR gamma chain. Molecular basis for CD89/FcR gamma chain association. J Biol Chem 270, 29781-29787 .
pmid:8530370
23 Owens, R.J., Burke, C., and Rose, J.K. (1994). Mutations in the membrane-spanning domain of the human immunodeficiency virus envelope glycoprotein that affect fusion activity. J Virol 68, 570-574 .
pmid:8254774
24 Pietschmann, T., Zentgraf, H., Rethwilm, A., and Lindemann, D. (2000). An evolutionarily conserved positively charged amino acid in the putative membrane-spanning domain of the foamy virus envelope protein controls fusion activity. J Virol 74, 4474-4482 .
pmid:10775583
25 Reeves, J.D., Gallo, S.A., Ahmad, N., Miamidian, J.L., Harvey, P.E., Sharron, M., Pohlmann, S., Sfakianos, J.N., Derdeyn, C.A., Blumenthal, R., (2002). Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics. Proc Natl Acad Sci U S A 99, 16249-16254 .
pmid:12444251
26 Rowell, J.F., Stanhope, P.E., and Siliciano, R.F. (1995). Endocytosis of endogenously synthesized HIV-1 envelope protein. Mechanism and role in processing for association with class II MHC. J Immunol 155, 473-488 .
pmid:7602119
27 Shang, L., and Hunter, E. (2010). Residues in the membrane-spanning domain core modulate conformation and fusogenicity of the HIV-1 envelope glycoprotein. Virology 404, 158-167 .
pmid:20605619
28 Shang, L., Yue, L., and Hunter, E. (2008). Role of the membrane-spanning domain of human immunodeficiency virus type 1 envelope glycoprotein in cell-cell fusion and virus infection. J Virol 82, 5417-5428 .
pmid:18353944
29 Weiss, C.D. (2003). HIV-1 gp41: mediator of fusion and target for inhibition. AIDS Rev 5, 214-221 .
pmid:15012000
30 Welman, M., Lemay, G., and Cohen, E.A. (2007). Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex. Virus Res 124, 103-112 .
pmid:17129629
31 Wilk, T., Pfeiffer, T., Bukovsky, A., Moldenhauer, G., and Bosch, V. (1996). Glycoprotein incorporation and HIV-1 infectivity despite exchange of the gp160 membrane-spanning domain. Virology 218, 269-274 .
pmid:8615034
32 Wyss, S., Dimitrov, A.S., Baribaud, F., Edwards, T.G., Blumenthal, R., and Hoxie, J.A. (2005). Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail. J Virol 79, 12231-12241 .
pmid:16160149
33 Yang, C., Spies, C.P., and Compans, R.W. (1995). The human and simian immunodeficiency virus envelope glycoprotein transmembrane subunits are palmitoylated. Proc Natl Acad Sci U S A 92, 9871-9875 .
pmid:7568235
[1] Xin Zhou, Yu He, Xiaofang Huang, Yuting Guo, Dong Li, Junjie Hu. Reciprocal regulation between lunapark and atlastin facilitates ER three-way junction formation[J]. Protein Cell, 2019, 10(7): 510-525.
[2] Huan Liu, Xiaojie Su, Lulu Si, Lu Lu, Shibo Jiang. The development of HIV vaccines targeting gp41 membrane-proximal external region (MPER): challenges and prospects[J]. Protein Cell, 2018, 9(7): 596-615.
[3] Mingyang Wang,Michael Veit. Hemagglutinin-esterase-fusion (HEF) protein of influenza C virus[J]. Protein Cell, 2016, 7(1): 28-45.
[4] Fuyun Wu,Xiaoyu Hu,Xin Bian,Xinqi Liu,Junjie Hu. Comparison of human and Drosophila atlastin GTPases[J]. Protein Cell, 2015, 6(2): 139-146.
[5] Lifang Niu, Falong Lu, Taolan Zhao, Chunyan Liu, Xiaofeng Cao. The enzymatic activity of Arabidopsis protein arginine methyltransferase 10 is essential for flowering time regulation[J]. Prot Cell, 2012, 3(6): 450-459.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed